SCHEMBL8649983

SCHEMBL8649983

COc1cc2ncnc(N3CCc4ccc(Cl)cc43)c2cc1Cl

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.64
CSF1R P07333 1/20 0.63
RET P07949 2/20 0.52
KIF5B P33176 1/20 0.52
KDR P35968 1/20 0.52
KIT P10721 3/20 0.48
ACHE P22303 2/20 0.47
BACE1 P56817 2/20 0.47
PDGFRB P09619 3/20 0.46
PDE10A Q9Y233 3/20 0.46
PDE1B Q01064 1/20 0.45
PDGFRA P16234 2/20 0.44
HTR1A P08908 1/20 0.43
ADRA1D P25100 1/20 0.43
HTR7 P34969 1/20 0.43
ADRA1A P35348 1/20 0.43
ADRA1B P35368 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8649000 0.93 EGFR (0.73) EGFRCSF1RRETKIF5BKDR
SCHEMBL9052816 0.88 EGFR (0.66) EGFRCSF1RRETKIF5BKDR
SCHEMBL8652205 0.88 EGFR (0.60) EGFRCSF1RRETKIF5BKDR
SCHEMBL8647145 0.87 EGFR (0.62) EGFRCSF1RRETKIF5BKDR
SCHEMBL8648185 0.87 EGFR (0.62) EGFRCSF1RRETKIF5BKDR
SCHEMBL7966368 0.86 EGFR (0.63) EGFRCSF1RRETKIF5BKDR
SCHEMBL8645752 0.85 EGFR (0.62) EGFRCSF1RRETKIF5BKDR
SCHEMBL8657810 0.85 EGFR (0.58) EGFRCSF1RRETKIF5BKDR
SCHEMBL8645023 0.84 EGFR (0.73) EGFRCSF1RRETKIF5BKDR
SCHEMBL9115449 0.84 EGFR (0.58) EGFRCSF1RRETKIF5BKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5736534-A HYPERPROLIFERATIVE DISEASES; INHIBITORS OF PROTEIN-TYROSINE KINASES SUCH AS EPIDERMAL GROWTH FACTOR RECEPTOR; BRAIN, LUNG, BREAST CANCER; PSORIASIS AND BENIGN PROSTATE HYPERPLASIA PFIZER INC. (US) 1998-04-07 US disclosed
WO-1995023141-A1 4-HETEROCYCLYL-SUBSTITUTED QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS PFIZER INC. (US) 1995-08-31 WO disclosed